JPMorgan Chase announced Wednesday the appointment of Sri Kosaraju as global chair of investment banking, focused on the firm’s healthcare vertical. Kosaraju returns to JPMorgan after serving as CEO of Inscripta, having previously spent 16 years building the bank’s healthcare franchise. Based in San Francisco, he will report to co-heads of global banking Filippo Gori and John Simmons. The move follows JPMorgan’s broader hiring push, including the recent appointment of Jerry Lee in a similar healthcare-focused role, as dealmaking activity is expected to remain strong through 2026.
In-Depth:
Jan 7 (Reuters) – JPMorgan Chase stated on Wednesday it has appointed Sri Kosaraju as a global chair of investment banking to support the firm’s healthcare industest vertical.
The shift comes as JPMorgan ramps up its investment banking push amid heightened dealcreating appetite, having poached senior bankers from Goldman Sachs and Deutsche Bank in October 2025.
Dealcreating is expected to remain strong in 2026, after a near record-breaking period for mergers and acquisitions despite a turbulent spring last year.
Kosaraju will rejoin JPMorgan from Inscripta, where he most recently served as CEO. He has previously spent 16 years at the bank, assisting build its healthcare franchise.
His appointment follows the recent hiring of Jerry Lee as global chair of investment banking with a healthcare focus, as JPMorgan continues to bring in senior talent to expand its global banking franchise.
In his new role, Kosaraju will be based in San Francisco and will report to Filippo Gori and John Simmons, co‑heads of global banking.
(Reporting by Pragyan Kalita in Bengaluru; Editing by Alan Barona)
